These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 445954)

  • 1. Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness.
    Rivera-Calimlim L; Griesbach PH; Perlmutter R
    Clin Pharmacol Ther; 1979 Jul; 26(1):114-21. PubMed ID: 445954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
    Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L
    Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in therapeutic blood monitoring of chlorpromazine.
    Rivera-Calimlim L
    Ther Drug Monit; 1982; 4(1):41-9. PubMed ID: 7041337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
    Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B; Alfredsson G
    Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol and chlorpromazine: a double-blind cross-over trial and clinical study in children and adolescents.
    Lewis PJ; James NM
    Aust N Z J Psychiatry; 1973 Mar; 7(1):59-65. PubMed ID: 4579394
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M; Gouws E; Miller R; Moodley SV
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lithium on plasma chlorpromazine levels.
    Rivera-Calimlim L; Kerzner B; Karch FE
    Clin Pharmacol Ther; 1978 Apr; 23(4):451-5. PubMed ID: 630793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with chlorprothixene in disturbed children. A comparative study.
    Harman C; Winn DA
    Int J Neuropsychiatry; 1966 Feb; 2(1):72-7. PubMed ID: 5907817
    [No Abstract]   [Full Text] [Related]  

  • 18. Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
    Shastri M; Alla L; Sabaratnam M
    J Psychopharmacol; 2006 Nov; 20(6):863-7. PubMed ID: 16891339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How long does chlorpromazine last?
    Lacoursiere RB; Spohn HE
    J Nerv Ment Dis; 1976 Oct; 163(4):267-75. PubMed ID: 972329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.